セメントレス人工膝関節全置換術市場：製品別、材料別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

セメントレス人工膝関節全置換術市場は、2022年に19億米ドルと評価され、2023年から2032年にかけてCAGR 4.6%で成長し、2032年には30億米ドルに達すると予測されています。

セメントレス人工膝関節全置換術の世界市場の成長を促進する主な要因には、関節リウマチやスポーツ関連傷害の有病率の増加、セメントレス人工膝関節全置換術の治療成績を大幅に改善したインプラントの設計、材料、手術手技の技術進歩などがあります。例えば、世界RAネットワークが発表した報告書によると、2021年には、世界で3億5,000万人以上が関節炎に罹患しており、世界人口の3％が乾癬性関節炎、1,400万人が関節リウマチに罹患していると報告されています、

さらに、人工膝関節置換術に使用される技術的に高度な医療機器の開発のための研究開発活動の急増や、急速に増加する老人人口が、市場の成長を促進する要因となっています。また、セメントレス人工膝関節置換術は、セメントインプラントと比較して、固定力が高い、ゆるみのリスクが低い、セメントに伴う合併症が少ない、再手術が容易であるなどの利点があるため、セメントレス人工膝関節置換術への移行が進み、セメントレス人工膝関節全置換術プラットフォームの採用が増加し、市場の成長を促進しています。

しかし、セメントレス人工膝関節インプラントに関連する高コストと、セメント人工膝関節のような代替品の容易な入手可能性が、市場成長の主な障壁となっています。それとは反対に、セメントレス・インプラントに対する患者の嗜好の高まりや、セメントレス人工膝関節置換術に対する有利な償還政策や保険適用が、将来的にセメントレス人工膝関節全置換術の世界市場拡大に有益な機会を提供すると期待されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場の定義と範囲
• 主な調査結果
  • 影響要因
  • 主な投資機会
• ポーターのファイブフォース分析
• 市場力学
  • 促進要因
    • 変形性膝関節症の有病率の上昇
    • 人工膝関節インプラントの技術的進歩
    • スポーツ関連傷害の増加
  • 抑制要因
    • セメントレス人工膝関節インプラントの高コスト
  • 機会
    • セメント人工膝関節よりもセメントレス人工膝関節全置換術の人気の上昇
• COVID-19市場への影響分析

第4章 セメントレス人工膝関節全置換術市場：製品別

• 概要
• 可動性ベアリング
• 固定ベアリング

第5章 セメントレス人工膝関節市場：材料別

• 概要
• セラミックス
• 合金
• その他

第6章 セメントレス人工膝関節市場：エンドユーザー別

• 概要
• 病院
• その他

第7章 セメントレス人工膝関節置換術市場セメントレス人工膝関節市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 日本
  • 中国
  • オーストラリア
  • インド
  • 韓国
  • その他
• ラテンアメリカ・中東・アフリカ
  • ブラジル
  • サウジアラビア
  • 南アフリカ
  • その他

第8章 競争情勢

• イントロダクション
• 主要成功戦略
• 主要10企業の製品マッピング
• 競合ダッシュボード
• 競合ヒートマップ
• 主要企業のポジショニング、2022年

第9章 企業プロファイル

• Zimmer Biomet Holding Inc.
• Stryker Corporation.
• Johnson & Johnson
• B. Braun Melsungen AG
• MicroPort Scientific Corporation
• Waldemar Link GmbH & Co. KG
• United Orthopedic Corporation
• X. NOV
• Smith & Nephew plc
• Olympus Corporation

LIST OF TABLES

• TABLE 01. GLOBAL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 02. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR MOBILE BEARINGS, BY REGION, 2022-2032 ($MILLION)
• TABLE 03. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR FIXED BEARINGS, BY REGION, 2022-2032 ($MILLION)
• TABLE 04. GLOBAL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 05. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR CERAMICS, BY REGION, 2022-2032 ($MILLION)
• TABLE 06. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR ALLOY, BY REGION, 2022-2032 ($MILLION)
• TABLE 07. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 08. GLOBAL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 09. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
• TABLE 10. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 11. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY REGION, 2022-2032 ($MILLION)
• TABLE 12. NORTH AMERICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 13. NORTH AMERICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 14. NORTH AMERICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 15. NORTH AMERICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 16. U.S. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 17. U.S. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 18. U.S. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 19. CANADA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 20. CANADA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 21. CANADA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 22. MEXICO CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 23. MEXICO CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 24. MEXICO CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 25. EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 26. EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 27. EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 28. EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 29. GERMANY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 30. GERMANY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 31. GERMANY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 32. FRANCE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 33. FRANCE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 34. FRANCE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 35. UK CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 36. UK CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 37. UK CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 38. ITALY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 39. ITALY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 40. ITALY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 41. SPAIN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 42. SPAIN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 43. SPAIN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 44. REST OF EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 45. REST OF EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 46. REST OF EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 47. ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 48. ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 49. ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 50. ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 51. JAPAN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 52. JAPAN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 53. JAPAN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 54. CHINA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 55. CHINA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 56. CHINA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 57. AUSTRALIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 58. AUSTRALIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 59. AUSTRALIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 60. INDIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 61. INDIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 62. INDIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 63. SOUTH KOREA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 64. SOUTH KOREA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 65. SOUTH KOREA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 66. REST OF ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 67. REST OF ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 68. REST OF ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 69. LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 70. LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 71. LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 72. LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 73. BRAZIL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 74. BRAZIL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 75. BRAZIL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 76. SAUDI ARABIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 77. SAUDI ARABIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 78. SAUDI ARABIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 79. SOUTH AFRICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 80. SOUTH AFRICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 81. SOUTH AFRICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 82. REST OF LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 83. REST OF LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)
• TABLE 84. REST OF LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 85. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
• TABLE 86. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
• TABLE 87. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS
• TABLE 88. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
• TABLE 89. ZIMMER BIOMET HOLDING INC.: KEY STRATERGIES
• TABLE 90. STRYKER CORPORATION.: KEY EXECUTIVES
• TABLE 91. STRYKER CORPORATION.: COMPANY SNAPSHOT
• TABLE 92. STRYKER CORPORATION.: PRODUCT SEGMENTS
• TABLE 93. STRYKER CORPORATION.: PRODUCT PORTFOLIO
• TABLE 94. JOHNSON & JOHNSON: KEY EXECUTIVES
• TABLE 95. JOHNSON & JOHNSON: COMPANY SNAPSHOT
• TABLE 96. JOHNSON & JOHNSON: PRODUCT SEGMENTS
• TABLE 97. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
• TABLE 98. JOHNSON & JOHNSON: KEY STRATERGIES
• TABLE 99. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
• TABLE 100. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
• TABLE 101. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS
• TABLE 102. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
• TABLE 103. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES
• TABLE 104. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
• TABLE 105. MICROPORT SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
• TABLE 106. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
• TABLE 107. WALDEMAR LINK GMBH & CO. KG: KEY EXECUTIVES
• TABLE 108. WALDEMAR LINK GMBH & CO. KG: COMPANY SNAPSHOT
• TABLE 109. WALDEMAR LINK GMBH & CO. KG: SERVICE SEGMENTS
• TABLE 110. WALDEMAR LINK GMBH & CO. KG: PRODUCT PORTFOLIO
• TABLE 111. UNITED ORTHOPEDIC CORPORATION: KEY EXECUTIVES
• TABLE 112. UNITED ORTHOPEDIC CORPORATION: COMPANY SNAPSHOT
• TABLE 113. UNITED ORTHOPEDIC CORPORATION: PRODUCT SEGMENTS
• TABLE 114. UNITED ORTHOPEDIC CORPORATION: SERVICE SEGMENTS
• TABLE 115. UNITED ORTHOPEDIC CORPORATION: PRODUCT PORTFOLIO
• TABLE 116. X. NOV: KEY EXECUTIVES
• TABLE 117. X. NOV: COMPANY SNAPSHOT
• TABLE 118. X. NOV: PRODUCT SEGMENTS
• TABLE 119. X. NOV: SERVICE SEGMENTS
• TABLE 120. X. NOV: PRODUCT PORTFOLIO
• TABLE 121. X. NOV: KEY STRATERGIES
• TABLE 122. SMITH & NEPHEW PLC: KEY EXECUTIVES
• TABLE 123. SMITH & NEPHEW PLC: COMPANY SNAPSHOT
• TABLE 124. SMITH & NEPHEW PLC: PRODUCT SEGMENTS
• TABLE 125. SMITH & NEPHEW PLC: PRODUCT PORTFOLIO
• TABLE 126. SMITH & NEPHEW PLC: KEY STRATERGIES
• TABLE 127. OLYMPUS CORPORATION: KEY EXECUTIVES
• TABLE 128. OLYMPUS CORPORATION: COMPANY SNAPSHOT
• TABLE 129. OLYMPUS CORPORATION: PRODUCT SEGMENTS
• TABLE 130. OLYMPUS CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

• FIGURE 01. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032
• FIGURE 02. SEGMENTATION OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032
• FIGURE 03. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET,2022-2032
• FIGURE 04. TOP INVESTMENT POCKETS IN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET (2023-2032)
• FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
• FIGURE 06. LOW THREAT OF NEW ENTRANTS
• FIGURE 07. LOW THREAT OF SUBSTITUTES
• FIGURE 08. LOW INTENSITY OF RIVALRY
• FIGURE 09. LOW BARGAINING POWER OF BUYERS
• FIGURE 10. GLOBAL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
• FIGURE 11. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022(%)
• FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR MOBILE BEARINGS, BY COUNTRY 2022-2032(%)
• FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR FIXED BEARINGS, BY COUNTRY 2022-2032(%)
• FIGURE 14. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022(%)
• FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR CERAMICS, BY COUNTRY 2022-2032(%)
• FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR ALLOY, BY COUNTRY 2022-2032(%)
• FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
• FIGURE 18. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022(%)
• FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR HOSPITALS, BY COUNTRY 2022-2032(%)
• FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
• FIGURE 21. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET BY REGION, 2022
• FIGURE 22. U.S. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 23. CANADA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 24. MEXICO CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 25. GERMANY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 26. FRANCE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 27. UK CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 28. ITALY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 29. SPAIN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 30. REST OF EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 31. JAPAN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 32. CHINA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 33. AUSTRALIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 34. INDIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 35. SOUTH KOREA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 36. REST OF ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 37. BRAZIL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 38. SAUDI ARABIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 39. SOUTH AFRICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 40. REST OF LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)
• FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
• FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
• FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
• FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 45. COMPETITIVE DASHBOARD
• FIGURE 46. COMPETITIVE HEATMAP: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET
• FIGURE 47. TOP PLAYER POSITIONING, 2022
• FIGURE 48. ZIMMER BIOMET HOLDING INC.: NET SALES, 2020-2022 ($MILLION)
• FIGURE 49. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 50. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 51. STRYKER CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 52. STRYKER CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 53. STRYKER CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 54. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
• FIGURE 55. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 56. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 57. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
• FIGURE 58. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 59. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 60. MICROPORT SCIENTIFIC CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 61. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 62. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 63. SMITH & NEPHEW PLC: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 64. SMITH & NEPHEW PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 65. SMITH & NEPHEW PLC: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 66. OLYMPUS CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 67. OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

According to a new report published by Allied Market Research, titled, "cementless total knee arthroplasty Market," The cementless total knee arthroplasty market was valued at $1.9 billion in 2022, and is estimated to reach $3 billion by 2032, growing at a CAGR of 4.6% from 2023 to 2032.

Major factors that drive the growth of the global cementless total knee arthroplasty market include increase in prevalence of rheumatoid arthritis and sports-related injuries, technological advancement in implant designs, materials, and surgical techniques that has significantly improved the outcomes of cementless knee arthroplasty. For instance, according to the report published by Global RA Network, in 2021, it has been reported that more than 350 million people have arthritis globally in which up to 3% of the global population has psoriatic arthritis and 14 million people have rheumatoid arthritis.,

Furthermore, the surge in the number of R&D activities for the development of technologically advanced medical devices used in knee arthroplasty and rapidly growing geriatric population are the factors that propel the growth of the market. In addition, the advantage of cementless knee arthroplasty over cemented implants such as better fixation, reduced risk of loosening, decreased complications associated with cement, and potential ease of revision surgeries leading to a shift toward cementless knee arthroplasty that increases the adoption of the cementless total knee arthroplasty platforms, thus propelling the market growth.

However, the high cost associated with cementless knee arthroplasty implants and easy availability of alternatives such as cemented knee arthroplasty are the major barriers to the growth of the market. On the contrary, growing patients' preference for cementless implants and favorable reimbursement policies and insurance coverage for cementless knee arthroplasty procedures are expected to offer remunerative opportunities for the expansion of the global cementless total knee arthroplasty market in the future.

The global cementless total knee arthroplasty market is segmented into product, material, end user, and region. On the basis of the product, the market is segmented into mobile bearings and fixed bearings. On the basis of the material, the market is segmented into ceramics, alloy, and others. Depending on end user, it is bifurcated into hospitals and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV. The major players in the market have adopted product launch and innovation as key developmental strategies to improve the product portfolio of the cementless total knee arthroplasty market.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cementless total knee arthroplasty market analysis from 2022 to 2032 to identify the prevailing cementless total knee arthroplasty market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cementless total knee arthroplasty market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cementless total knee arthroplasty market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Average Selling Price Analysis / Price Point Analysis
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By Product

• Mobile Bearings
• Fixed Bearings

By Material

• Ceramics
• Alloy
• Others

By End User

• Hospitals
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• B. Braun Melsungen AG
• Johnson & Johnson
• MicroPort Scientific Corporation
• Olympus Corporation
• Smith & Nephew plc
• Stryker Corporation.
• United Orthopedic Corporation
• Waldemar Link GmbH & Co. KG
• X. NOV
• Zimmer Biomet Holding Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in prevalence of knee osteoarthritis
    • 3.4.1.2. Technological advancements in knee arthroplasty implants
    • 3.4.1.3. Rise in the number of sports related injuries

• 3.4.2. Restraints
  • 3.4.2.1. High cost of cementless knee arthroplasty implants

• 3.4.3. Opportunities
  • 3.4.3.1. Rise in popularity of cementless total knee arthroplasty over cemented knee arthroplasty

• 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Mobile Bearings
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Fixed Bearings
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Ceramics
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Alloy
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Others
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country

CHAPTER 6: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Others
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country

CHAPTER 7: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key trends and opportunities
  • 7.2.2. Market size and forecast, by Product
  • 7.2.3. Market size and forecast, by Material
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Key market trends, growth factors and opportunities
    • 7.2.5.1.2. Market size and forecast, by Product
    • 7.2.5.1.3. Market size and forecast, by Material
    • 7.2.5.1.4. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Key market trends, growth factors and opportunities
    • 7.2.5.2.2. Market size and forecast, by Product
    • 7.2.5.2.3. Market size and forecast, by Material
    • 7.2.5.2.4. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Key market trends, growth factors and opportunities
    • 7.2.5.3.2. Market size and forecast, by Product
    • 7.2.5.3.3. Market size and forecast, by Material
    • 7.2.5.3.4. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key trends and opportunities
  • 7.3.2. Market size and forecast, by Product
  • 7.3.3. Market size and forecast, by Material
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Key market trends, growth factors and opportunities
    • 7.3.5.1.2. Market size and forecast, by Product
    • 7.3.5.1.3. Market size and forecast, by Material
    • 7.3.5.1.4. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Key market trends, growth factors and opportunities
    • 7.3.5.2.2. Market size and forecast, by Product
    • 7.3.5.2.3. Market size and forecast, by Material
    • 7.3.5.2.4. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Key market trends, growth factors and opportunities
    • 7.3.5.3.2. Market size and forecast, by Product
    • 7.3.5.3.3. Market size and forecast, by Material
    • 7.3.5.3.4. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Key market trends, growth factors and opportunities
    • 7.3.5.4.2. Market size and forecast, by Product
    • 7.3.5.4.3. Market size and forecast, by Material
    • 7.3.5.4.4. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Key market trends, growth factors and opportunities
    • 7.3.5.5.2. Market size and forecast, by Product
    • 7.3.5.5.3. Market size and forecast, by Material
    • 7.3.5.5.4. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Key market trends, growth factors and opportunities
    • 7.3.5.6.2. Market size and forecast, by Product
    • 7.3.5.6.3. Market size and forecast, by Material
    • 7.3.5.6.4. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key trends and opportunities
  • 7.4.2. Market size and forecast, by Product
  • 7.4.3. Market size and forecast, by Material
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Key market trends, growth factors and opportunities
    • 7.4.5.1.2. Market size and forecast, by Product
    • 7.4.5.1.3. Market size and forecast, by Material
    • 7.4.5.1.4. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Key market trends, growth factors and opportunities
    • 7.4.5.2.2. Market size and forecast, by Product
    • 7.4.5.2.3. Market size and forecast, by Material
    • 7.4.5.2.4. Market size and forecast, by End User
    • 7.4.5.3. Australia
    • 7.4.5.3.1. Key market trends, growth factors and opportunities
    • 7.4.5.3.2. Market size and forecast, by Product
    • 7.4.5.3.3. Market size and forecast, by Material
    • 7.4.5.3.4. Market size and forecast, by End User
    • 7.4.5.4. India
    • 7.4.5.4.1. Key market trends, growth factors and opportunities
    • 7.4.5.4.2. Market size and forecast, by Product
    • 7.4.5.4.3. Market size and forecast, by Material
    • 7.4.5.4.4. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Key market trends, growth factors and opportunities
    • 7.4.5.5.2. Market size and forecast, by Product
    • 7.4.5.5.3. Market size and forecast, by Material
    • 7.4.5.5.4. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Key market trends, growth factors and opportunities
    • 7.4.5.6.2. Market size and forecast, by Product
    • 7.4.5.6.3. Market size and forecast, by Material
    • 7.4.5.6.4. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key trends and opportunities
  • 7.5.2. Market size and forecast, by Product
  • 7.5.3. Market size and forecast, by Material
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Key market trends, growth factors and opportunities
    • 7.5.5.1.2. Market size and forecast, by Product
    • 7.5.5.1.3. Market size and forecast, by Material
    • 7.5.5.1.4. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Key market trends, growth factors and opportunities
    • 7.5.5.2.2. Market size and forecast, by Product
    • 7.5.5.2.3. Market size and forecast, by Material
    • 7.5.5.2.4. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Key market trends, growth factors and opportunities
    • 7.5.5.3.2. Market size and forecast, by Product
    • 7.5.5.3.3. Market size and forecast, by Material
    • 7.5.5.3.4. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Key market trends, growth factors and opportunities
    • 7.5.5.4.2. Market size and forecast, by Product
    • 7.5.5.4.3. Market size and forecast, by Material
    • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Zimmer Biomet Holding Inc.
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
  • 9.1.7. Key strategic moves and developments
• 9.2. Stryker Corporation.
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
• 9.3. Johnson & Johnson
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
  • 9.3.7. Key strategic moves and developments
• 9.4. B. Braun Melsungen AG
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. MicroPort Scientific Corporation
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
• 9.6. Waldemar Link GmbH & Co. KG
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
• 9.7. United Orthopedic Corporation
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
• 9.8. X. NOV
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Key strategic moves and developments
• 9.9. Smith & Nephew plc
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
  • 9.9.7. Key strategic moves and developments
• 9.10. Olympus Corporation
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance